213 related articles for article (PubMed ID: 19689266)
1. Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?
Hillas G; Loukides S; Kostikas K; Bakakos P
Curr Med Chem; 2009; 16(22):2824-38. PubMed ID: 19689266
[TBL] [Abstract][Full Text] [Related]
2. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.
Santini G; Mores N; Shohreh R; Valente S; Dabrowska M; Trové A; Zini G; Cattani P; Fuso L; Mautone A; Mondino C; Pagliari G; Sala A; Folco G; Aiello M; Pisi R; Chetta A; Losi M; Clini E; Ciabattoni G; Montuschi P
J Breath Res; 2016 Jan; 10(1):017102. PubMed ID: 26814886
[TBL] [Abstract][Full Text] [Related]
3. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.
Guo Y; Hong C; Liu Y; Chen H; Huang X; Hong M
Medicine (Baltimore); 2018 Jun; 97(23):e10857. PubMed ID: 29879019
[TBL] [Abstract][Full Text] [Related]
5. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma.
Tseliou E; Bessa V; Hillas G; Delimpoura V; Papadaki G; Roussos C; Papiris S; Bakakos P; Loukides S
Chest; 2010 Jul; 138(1):107-13. PubMed ID: 20173051
[TBL] [Abstract][Full Text] [Related]
6. Exhaled biomarkers.
Kharitonov SA; Barnes PJ
Chest; 2006 Nov; 130(5):1541-6. PubMed ID: 17099035
[TBL] [Abstract][Full Text] [Related]
7. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
8. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.
Soter S; Barta I; Antus B
Inflammation; 2013 Oct; 36(5):1178-85. PubMed ID: 23681903
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in asthma biomarker research.
Leung TF; Ko FW; Wong GW
Ther Adv Respir Dis; 2013 Oct; 7(5):297-308. PubMed ID: 23907809
[TBL] [Abstract][Full Text] [Related]
10. FENO measurement and sputum analysis for diagnosing asthma in clinical practice.
Schneider A; Schwarzbach J; Faderl B; Welker L; Karsch-Völk M; Jörres RA
Respir Med; 2013 Feb; 107(2):209-16. PubMed ID: 23107283
[TBL] [Abstract][Full Text] [Related]
11. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: implications for application in clinical practice.
Bessa V; Tseliou E; Bakakos P; Loukides S
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):226-32; quiz 232-4, 278. PubMed ID: 18814444
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD.
Rytilä P; Rehn T; Ilumets H; Rouhos A; Sovijärvi A; Myllärniemi M; Kinnula VL
Respir Res; 2006 Apr; 7(1):69. PubMed ID: 16646959
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath condensate biomarkers in COPD.
Borrill ZL; Roy K; Singh D
Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
[TBL] [Abstract][Full Text] [Related]
15. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of some pulmonary diseases in exhaled breath.
Kharitonov SA; Barnes PJ
Biomarkers; 2002; 7(1):1-32. PubMed ID: 12101782
[TBL] [Abstract][Full Text] [Related]
18. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD.
Chou KT; Su KC; Huang SF; Hsiao YH; Tseng CM; Su VY; Hung SC; Perng DW
Lung; 2014 Aug; 192(4):499-504. PubMed ID: 24816967
[TBL] [Abstract][Full Text] [Related]
19. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
[TBL] [Abstract][Full Text] [Related]
20. An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice.
Matsunaga K; Kuwahira I; Hanaoka M; Saito J; Tsuburai T; Fukunaga K; Matsumoto H; Sugiura H; Ichinose M;
Respir Investig; 2021 Jan; 59(1):34-52. PubMed ID: 32773326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
